Cutting the brakes and flooring the gas: How TMEPAI turns TGF-β into a tumor promoter

Genes and Cancer

Volumn 5, Issue 9-10, 2014, Pages 303-305

  Cichon, Magdalena A ^a   Radisky, Derek C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast cancer; TGF beta; TMEPAI

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER PROGNOSIS; HUMAN; MICROARRAY ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR PROMOTION;

EID: 84949562430     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Massague J: TGFbeta in Cancer. Cell 2008, 134(2):215-230.
2. Lamouille S, Xu J, Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014, 15(3):178-196.
3. Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C, Grippo PJ: TGF-beta: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst 2014, 106(2):369.
4. Mu Y, Gudey SK, Landstrom M: Non-Smad signaling pathways. Cell Tissue Res 2012, 347(1):11-20.
5. Hough C, Radu M, Dore JJ: Tgf-beta induced Erk phosphorylation of smad linker region regulates smad signaling. PLoS One 2012, 7(8):e42513.
6. Watanabe Y, Itoh S, Goto T, Ohnishi E, Inamitsu M, Itoh F, Satoh K, Wiercinska E, Yang W, Shi L et al: TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling. Mol Cell 2010, 37(1):123-134.
7. Singha PK, Yeh IT, Venkatachalam MA, Saikumar P: Transforming growth factor-beta (TGF-beta)-inducible gene TMEPAI converts TGF-beta from a tumor suppressor to a tumor promoter in breast cancer. Cancer Res 2010, 70(15):6377-6383.
8. Nakano N, Itoh S, Watanabe Y, Maeyama K, Itoh F, Kato M: Requirement of TCF7L2 for TGF-beta-dependent transcriptional activation of the TMEPAI gene. J Biol Chem 2010, 285(49):38023-38033.
9. Singha PK, Pandeswara S, Geng H, Lan R, Venkatachalam MA, Saikumar P: TGF-beta induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes noncanonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer. Genes & Cancer 2014.
10. Foulkes WD, Smith IE, Reis-Filho JS: Triple-negative breast cancer. N Engl J Med 2010, 363(20):1938-1948.
11. Ringner M, Fredlund E, Hakkinen J, Borg A, Staaf J: GOBO: gene expression-based outcome for breast cancer online. PLoS One 2011, 6(3):e17911.
12. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z et al: Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009, 27(8):1160-1167.
13. Chow A, Arteaga CL, Wang SE: When tumor suppressor TGFbeta meets the HER2 (ERBB2) oncogene. J Mammary Gland Biol Neoplasia 2011, 16(2):81-88.
14. Arteaga CL, Sliwkowski MX, Osborne CK, Perez EA, Puglisi F, Gianni L: Treatment of HER2-positive breast cancer: current status and future perspectives. Nat Rev Clin Oncol 2012, 9(1):16-32.